Steven Snapinn

15.2k citations
115 papers · 11.2k · 2 hit papers · h-index 33

Impact in

  • Nephrology top 0.1%
    • Chronic Kidney Disease and Diabetes
    • Dialysis and Renal Disease Management
    • Blood Pressure and Hypertension Studies
    • Renin-Angiotensin System Studies
    • Heart Failure Treatment and Management

Papers in

Steven Snapinn

111 papers receiving 10.4k citations

Steven Snapinn's Hit Papers

Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol 2002 · 1.2k citations
1.2k0+8+16Years since publication10002.0k3.0k4.0k5.0k

Peers

Steven Snapinn
Comparison fields: 5 of 159
  • Nephrology 2.5k
  • Cardiology and Cardiovascular Medicine 5.1k
  • Endocrinology, Diabetes and Metabolism 3.1k
  • Statistics and Probability 632
  • Transplantation 97
Replace Raymond P. Bain with:
Raymond P. Bain United States
Shahnaz Shahinfar United States
Sharon Anderson United States
K. Borch‐Johnsen Denmark
Richard H. Grimm United States
Mihai Gheorghiade United States
Mikhail Kosiborod United States
Hans‐Henrik Parving Denmark
Brian Claggett United States
David Fitchett Canada
Steven Snapinn relative to Raymond P. Bain United States Raymond P. Bain's profile →
Citations per field
00.5×6.1×
Raymond P. Bain · 1×
Citations per year

Countries citing papers authored by Steven Snapinn

Since Specialization
Citations

This map shows the geographic impact of Steven Snapinn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven Snapinn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven Snapinn more than expected).

Fields of papers citing papers by Steven Snapinn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven Snapinn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven Snapinn. The network helps show where Steven Snapinn may publish in the future.

Co-authors

The 25 scholars most cited alongside Steven Snapinn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Steven Snapinn Line = papers co-authored together Steven Snapinn links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 115 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy
Hit paper breakdown →
20015706
2
Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
Hit paper breakdown →
20021163
3 2003435
4 2002372
5 2002333
6 2003202
7 2000190
8 2005190
9 1999164
10 2006161
11 2007126
12 200497
13
A comparison of methodologies in detection of the anaerobic threshold.
199088
14 200585
15 200679
16 200475
17 200275
18
[Effect of losartan on renal and cardiovascular complications of patients with type 2 diabetes and nephropathy].
200174
19 200672
20 200070

About Steven Snapinn

Steven Snapinn is a scholar working on Statistics and Probability, Cardiology and Cardiovascular Medicine, Economics and Econometrics, Statistics, Probability and Uncertainty and Management Science and Operations Research, having authored 115 papers that have together received 11.2k indexed citations. Recurring topics across this work include Statistical Methods in Clinical Trials (44 papers), Health Systems, Economic Evaluations, Quality of Life (21 papers), Advanced Causal Inference Techniques (15 papers), Blood Pressure and Hypertension Studies (11 papers), Statistical Methods and Inference (11 papers), Optimal Experimental Design Methods (11 papers), Meta-analysis and systematic reviews (10 papers) and Statistical Methods and Bayesian Inference (10 papers). The work is most often cited by research in Nephrology (2.5k citations), Cardiology and Cardiovascular Medicine (5.1k citations), Endocrinology, Diabetes and Metabolism (3.1k citations), Statistics and Probability (632 citations) and Transplantation (97 citations). Steven Snapinn has collaborated with scholars based in United States, Sweden and Denmark. Frequent co-authors include Shahnaz Shahinfar, Barry M. Brenner, Dick de Zeeuw, William F. Keane, William E. Mitch, Giuseppe Remuzzi, Mark E. Cooper, Hans‐Henrik Parving, Qi Jiang and Jonathan M. Edelman. Their work appears in journals such as Statistics in Medicine, Statistics in Biopharmaceutical Research, Circulation, The American Journal of Cardiology and Pharmaceutical Statistics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact